Advantages and Outcomes of Epithelium-On Crosslinking
Update: 2025-11-20
Description
In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
